Quest Diagnostics has completed the acquisition of select assets of NewYork-Presbyterian’s laboratory services business. The financial details of the transaction were not disclosed. Quest Diagnostics and NewYork-Presbyterian aim to collaborate in providing high-quality, affordable testing to both providers and patients, combining the complementary strengths of both organizations. Patients will also benefit from Quest’s network of nearly 100 patient service centers in the five boroughs. Quest Diagnostics provides a complete portfolio of services to health systems and hospitals to improve the quality, innovation, and insights of their diagnostic laboratory services.
Quest Diagnostics (NYSE:DGX), the nation’s leading provider of diagnostic information services, and NewYork-Presbyterian, one of the nation’s largest and most comprehensive academic medical centers, today announced that Quest has completed its previously announced acquisition of select assets of the laboratory services business of NewYork-Presbyterian. Financial details of the transaction were not disclosed.
The goal of the collaboration is to enable providers and patients to access high quality, affordable testing from a service menu that combines the complementary strengths of both organizations. In addition, patients will benefit from access to Quest’s network of nearly 100 patient service centers in the five boroughs.
Quest provides a complete portfolio of services to empower health systems and hospitals to improve the quality, innovation and insights of their diagnostic laboratory services, elevate the patient experience and lower costs for more accessible—and affordable—care. For more information, visit Hospitals & Health Systems | Quest Diagnostics.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: BioSpace
